E-DRUG: UU-WHO winter meeting 6 + 7 Jan 2016
---------------------------------------------------------------------------
Dear E-Druggers,
The WHO Collaborating Centre for Pharmaceutical Policy and Regulation (head: Prof. Dr. Bert Leufkens) in collaboration with the Department of Essential Medicines and Health Products, WHO (Dr. Gilles Forte) will organise a Winter Meeting for researchers in the field of pharmaceutical policy analysis. As in previous years, we have chosen to combine a central theme with key note lectures and a plenary discussion on the first day with the opportunity for (young) researchers to discuss their work, and plans for work, with peers and faculty on the second day of the meeting.
You are cordially invited to attend this meeting!
Contents of the meeting
The first day of the meeting will focus on “Globalisation of clinical trials: policy, regulatory and ethical reflections”. Clinical trials remain the mainstay for building evidence for whether and how medicines work. Over the past decades, we have seen an increasing shift in the conduct of clinical trials from high income to low and middle income countries. This shift on a global scale has led to a dynamic debate about potential effects on trial external validity, extrapolation of evidence to other regions and populations, and inherent policy, regulatory and ethical questions. Invited speakers will present their views on this topic during plenary lectures and participants are strongly invited to contribute to the dialogue.
On the second day of the meeting, submitted abstracts will be presented and discussed in the morning and afternoon (oral and poster presentations). Abstracts are not limited to the central theme of the first day; all research in the field of pharmaceutical policy analysis is eligible for submission. The focus of the sessions will be on methods used or proposed. The presentations should be for a maximum time of 15 minutes and should be based on a maximum of 10 PowerPoint slides. All sessions will be chaired by senior researchers. Full papers should not be submitted in advance.
Abstracts for presentations
Abstracts should relate to planned or ongoing research and should at least state rationale, objective(s) and methods. Where possible early results can be presented. Abstracts should be in English. Text should not exceed 300 words. Abstracts for presentations must be submitted before 22 November 2015 using the template. This template can be found using the following link;
https://drive.google.com/file/d/0ByPOpJF1NQe6MzN3bmp0d1gxaTA/view?usp=sharing.
You will be informed whether your abstract is accepted by 15 December. Only one abstract should be submitted from a single person because of the limited number of abstracts that can be presented.
Target group
The primary target group for participation in this winter meeting are Masters and PhD students directly related to or closely working with any WHO Collaborating Centre. However, other Masters and PhD students, post docs and (senior) researchers who have an interest in the policy aspects of pharmaceuticals are welcome to submit abstracts. The maximum number of participants is expected to be 60.
Meeting details
The conference venue is the Faculty Club, Achter de Dom 7a, Utrecht, the Netherlands. The meeting will start 6 Jan 2016 at 10.00 am and will close at 16:00 on 7 Jan 2016. The final programme will be based on abstract submissions and will be sent to all attendees before 1 Jan 2016.
Please register before 15 Dec 2015 through the following link;
http://goo.gl/forms/TxHG3WyZT9.
The meeting is free for all participants and will include coffee, tea, lunch, drinks on Monday and an abstract book.
A limited number of scholarships including international travel and accommodation is available for participants from low and middle income countries who have submitted an abstract which has been selected for an oral presentation. If you wish to apply for a scholarship you need to clearly indicate this is your message at time of abstract submission. Please note that for all other participants travel funding and accommodation are at participants’ own expenses. The meeting organisers will not be able to assist with accommodation or travel arrangements.
Contact information
Please send enquiries and abstracts to
Pruscha Rasul (e-mail; uu.who.wintermeeting@gmail.com
Kind regards,
Aukje Mantel
Aukje Mantel-Teeuwisse, PhD
Director School of Pharmacy, Utrecht University (http://students.uu.nl/beta/farmacie-m)
Managing director WHO Collaborating Centre for Pharmaceutical Policy and Regulation
Division Pharmacoepidemiology & Clinical Pharmacology
David de Wied building | Universiteitsweg
TB Utrecht | The Netherlands
"Mantel-Teeuwisse, A.K. (Aukje)" <A.K.Mantel@uu.nl>